0.99
-0.0117(-1.17%)
Currency In USD
| Previous Close | 1 |
| Open | 1 |
| Day High | 1 |
| Day Low | 0.97 |
| 52-Week High | 1.59 |
| 52-Week Low | 0.7 |
| Volume | 55,225 |
| Average Volume | 271,625 |
| Market Cap | 54.19M |
| PE | -2.75 |
| EPS | -0.36 |
| Moving Average 50 Days | 0.95 |
| Moving Average 200 Days | 0.99 |
| Change | -0.01 |
If you invested $1000 in Cytosorbents Corporation (CTSO) 10 years ago, it would be worth $123.08 as of February 05, 2025 at a share price of $0.988. Whereas If you bought $1000 worth of Cytosorbents Corporation (CTSO) shares 5 years ago, it would be worth $182.01 as of February 05, 2025 at a share price of $0.988.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
GlobeNewswire Inc.
Jan 13, 2025 12:00 PM GMT
Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, Unlocking $5.0 Million in Restricted Cash Currently on the Balance Sheet PRINCETON, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
GlobeNewswire Inc.
Jan 06, 2025 12:00 PM GMT
PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the openin
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
GlobeNewswire Inc.
Jan 03, 2025 12:00 PM GMT
Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor meetings in San Francisco during J.P. Morgan Healthcare Confere